ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH

NCT00290030 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

800

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Hyperplasia
Acute Urinary Retention

Interventions

DRUG: Alfuzosin

Sponsor

Sanofi